Reduction of Alzheimer's disease amyloid-β in plasma by hemodialysis and its relation to cognitive functions

Nobuya Kitaguchi, Kazunori Kawaguchi, S. Nakai, K. Murakami, S. Ito, H. Hoshino, Hideo Hori, Atsushi Ohashi, Y. Shimano, N. Suzuki, Yukio Yuzawa, T. Mutoh, S. Sugiyama

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background/Aims: Rapid removal of plasma amyloid-β (Aβ) by blood purification may serve as a peripheral Aβ sink from the brain for Alzheimer's disease therapy. We investigated the reduction of plasma Aβ during hemodialysis and cognitive states. Methods: Aβ concentrations and Mini-Mental State Examinations (MMSE) were investigated in 37 hemodialysis patients (68.9 ± 4.1 years). Results: The dialyzers effectively removed Aβ 1-40 and Aβ 1-42 , 63.9 ± 14.4 and 51.6 ± 17.0% at 4 h dialysis, resulting in the reduction of Aβs in whole-body circulation by 51.1 ± 8.9 and 32.7 ± 12.0%, respectively. Although the plasma Aβs before dialysis (750.8 ± 171.3 pg/ml for Aβ 1-40 ) were higher than those reported for Alzheimer's disease patients, the cognitive states of hemodialysis patients were relatively normal, especially of longer dialysis vintages. Conclusions: Dialyzers effectively reduced Aβs in whole-body circulation. Repeated rapid decrease of plasma Aβs might maintain cognitive state.

Original languageEnglish
Pages (from-to)57-62
Number of pages6
JournalBlood Purification
Volume32
Issue number1
DOIs
Publication statusPublished - 01-07-2011

Fingerprint

Amyloid
Cognition
Renal Dialysis
Alzheimer Disease
Dialysis
Brain Diseases
Therapeutics

All Science Journal Classification (ASJC) codes

  • Hematology
  • Nephrology

Cite this

Kitaguchi, Nobuya ; Kawaguchi, Kazunori ; Nakai, S. ; Murakami, K. ; Ito, S. ; Hoshino, H. ; Hori, Hideo ; Ohashi, Atsushi ; Shimano, Y. ; Suzuki, N. ; Yuzawa, Yukio ; Mutoh, T. ; Sugiyama, S. / Reduction of Alzheimer's disease amyloid-β in plasma by hemodialysis and its relation to cognitive functions. In: Blood Purification. 2011 ; Vol. 32, No. 1. pp. 57-62.
@article{cadb6677e4074cbcb31a48d00c4c0f95,
title = "Reduction of Alzheimer's disease amyloid-β in plasma by hemodialysis and its relation to cognitive functions",
abstract = "Background/Aims: Rapid removal of plasma amyloid-β (Aβ) by blood purification may serve as a peripheral Aβ sink from the brain for Alzheimer's disease therapy. We investigated the reduction of plasma Aβ during hemodialysis and cognitive states. Methods: Aβ concentrations and Mini-Mental State Examinations (MMSE) were investigated in 37 hemodialysis patients (68.9 ± 4.1 years). Results: The dialyzers effectively removed Aβ 1-40 and Aβ 1-42 , 63.9 ± 14.4 and 51.6 ± 17.0{\%} at 4 h dialysis, resulting in the reduction of Aβs in whole-body circulation by 51.1 ± 8.9 and 32.7 ± 12.0{\%}, respectively. Although the plasma Aβs before dialysis (750.8 ± 171.3 pg/ml for Aβ 1-40 ) were higher than those reported for Alzheimer's disease patients, the cognitive states of hemodialysis patients were relatively normal, especially of longer dialysis vintages. Conclusions: Dialyzers effectively reduced Aβs in whole-body circulation. Repeated rapid decrease of plasma Aβs might maintain cognitive state.",
author = "Nobuya Kitaguchi and Kazunori Kawaguchi and S. Nakai and K. Murakami and S. Ito and H. Hoshino and Hideo Hori and Atsushi Ohashi and Y. Shimano and N. Suzuki and Yukio Yuzawa and T. Mutoh and S. Sugiyama",
year = "2011",
month = "7",
day = "1",
doi = "10.1159/000322624",
language = "English",
volume = "32",
pages = "57--62",
journal = "Blood Purification",
issn = "0253-5068",
publisher = "S. Karger AG",
number = "1",

}

Reduction of Alzheimer's disease amyloid-β in plasma by hemodialysis and its relation to cognitive functions. / Kitaguchi, Nobuya; Kawaguchi, Kazunori; Nakai, S.; Murakami, K.; Ito, S.; Hoshino, H.; Hori, Hideo; Ohashi, Atsushi; Shimano, Y.; Suzuki, N.; Yuzawa, Yukio; Mutoh, T.; Sugiyama, S.

In: Blood Purification, Vol. 32, No. 1, 01.07.2011, p. 57-62.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Reduction of Alzheimer's disease amyloid-β in plasma by hemodialysis and its relation to cognitive functions

AU - Kitaguchi, Nobuya

AU - Kawaguchi, Kazunori

AU - Nakai, S.

AU - Murakami, K.

AU - Ito, S.

AU - Hoshino, H.

AU - Hori, Hideo

AU - Ohashi, Atsushi

AU - Shimano, Y.

AU - Suzuki, N.

AU - Yuzawa, Yukio

AU - Mutoh, T.

AU - Sugiyama, S.

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Background/Aims: Rapid removal of plasma amyloid-β (Aβ) by blood purification may serve as a peripheral Aβ sink from the brain for Alzheimer's disease therapy. We investigated the reduction of plasma Aβ during hemodialysis and cognitive states. Methods: Aβ concentrations and Mini-Mental State Examinations (MMSE) were investigated in 37 hemodialysis patients (68.9 ± 4.1 years). Results: The dialyzers effectively removed Aβ 1-40 and Aβ 1-42 , 63.9 ± 14.4 and 51.6 ± 17.0% at 4 h dialysis, resulting in the reduction of Aβs in whole-body circulation by 51.1 ± 8.9 and 32.7 ± 12.0%, respectively. Although the plasma Aβs before dialysis (750.8 ± 171.3 pg/ml for Aβ 1-40 ) were higher than those reported for Alzheimer's disease patients, the cognitive states of hemodialysis patients were relatively normal, especially of longer dialysis vintages. Conclusions: Dialyzers effectively reduced Aβs in whole-body circulation. Repeated rapid decrease of plasma Aβs might maintain cognitive state.

AB - Background/Aims: Rapid removal of plasma amyloid-β (Aβ) by blood purification may serve as a peripheral Aβ sink from the brain for Alzheimer's disease therapy. We investigated the reduction of plasma Aβ during hemodialysis and cognitive states. Methods: Aβ concentrations and Mini-Mental State Examinations (MMSE) were investigated in 37 hemodialysis patients (68.9 ± 4.1 years). Results: The dialyzers effectively removed Aβ 1-40 and Aβ 1-42 , 63.9 ± 14.4 and 51.6 ± 17.0% at 4 h dialysis, resulting in the reduction of Aβs in whole-body circulation by 51.1 ± 8.9 and 32.7 ± 12.0%, respectively. Although the plasma Aβs before dialysis (750.8 ± 171.3 pg/ml for Aβ 1-40 ) were higher than those reported for Alzheimer's disease patients, the cognitive states of hemodialysis patients were relatively normal, especially of longer dialysis vintages. Conclusions: Dialyzers effectively reduced Aβs in whole-body circulation. Repeated rapid decrease of plasma Aβs might maintain cognitive state.

UR - http://www.scopus.com/inward/record.url?scp=79951854134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951854134&partnerID=8YFLogxK

U2 - 10.1159/000322624

DO - 10.1159/000322624

M3 - Article

VL - 32

SP - 57

EP - 62

JO - Blood Purification

JF - Blood Purification

SN - 0253-5068

IS - 1

ER -